BD Announces Third Quarter Fiscal 2026 Financial Results
Medical technology company BD (Becton, Dickinson and Company) will announce its financial results for the third quarter of fiscal year 2026 on August 6, 2026. Management will host a webcast to discuss the results and provide a business update.
Franklin Lakes, N.J. – BD (Becton, Dickinson and Company), a global medical technology company, announced it will report its financial results for the third quarter of fiscal year 2026, which ended June 30, 2026, via a webcast on August 6, 2026. The company will issue a news release and related presentation materials prior to the webcast.
Management will host an audio webcast at 8 a.m. ET on August 6 to discuss the company's third-quarter financial performance and provide an update on its operations and strategy. The webcast can be accessed on BD's investor relations website at www.bd.com/investors. A replay will be available on the same website after the call.
The press release and presentation materials, including summary financial information, will also be posted on the investor relations website. BD is a major player in the medical technology sector, focusing on advancing health through innovation in areas such as medical essentials, connected care, and biopharmaceutical systems.
The company supports healthcare professionals globally by developing technologies and solutions aimed at optimizing clinical operations and improving patient care outcomes. With a broad portfolio of products, BD aims to enhance safety, efficiency, and access to healthcare worldwide.